Abstract: |
The PML tumor suppressor controls key pathways for growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in human tumors through unknown posttranslational mechanisms. Casein kinase 2 (CK2) is oncogenic and frequently upregulated in human tumors. Here we show that CK2 regulates PML protein levels by promoting its ubiquitin-mediated degradation dependent on direct phosphorylation at Ser517. Consequently, PML mutants that are resistant to CK2 phosphorylation display increased tumor-suppressive functions. In a faithful mouse model of lung cancer, we demonstrate that Pml inactivation leads to increased tumorigenesis. Furthermore, CK2 pharmacological inhibition enhances the PML tumor-suppressive property in vivo. Importantly, we found an inverse correlation between CK2 kinase activity and PML protein levels in human lung cancer-derived cell lines and primary specimens. These data identify a key posttranslational mechanism that controls PML protein levels and provide therapeutic means toward PML restoration through CK2 inhibition. © 2006 Elsevier Inc. All rights reserved. |
Keywords: |
controlled study; human tissue; protein phosphorylation; human cell; sequence deletion; nonhuman; ubiquitin; animal cell; mouse; animals; mice; animal tissue; apoptosis; enzyme inhibition; proteasome endopeptidase complex; amino acid substitution; serine; carcinoma, non-small-cell lung; lung neoplasms; neoplasm proteins; cell line; animal experiment; animal model; rna, small interfering; lung cancer; in vivo study; enzyme activation; enzyme activity; cell line, tumor; phosphorylation; carcinogenesis; mice, transgenic; transcription factors; nuclear proteins; cancer inhibition; ubiquitination; amino acid sequence; molecular sequence data; enzyme inhibitors; tumor suppressor proteins; cell line, transformed; green fluorescent proteins; protein structure, tertiary; protein subunits; triazoles; nih 3t3 cells; genes, tumor suppressor; promyelocytic leukemia protein; leupeptins; sorbitol; p38 mitogen-activated protein kinases; trans-activation (genetics); casein kinase ii; hemagglutinins
|